HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells
- 28 October 2010
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 296 (2), 233-240
- https://doi.org/10.1016/j.canlet.2010.04.014
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Repo-Man Controls a Protein Phosphatase 1-Dependent Threshold for DNA Damage Checkpoint ActivationCurrent Biology, 2010
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Bone marrow microenvironment and the identification of new targets for myeloma therapyLeukemia, 2008
- Sp1-Mediated TRAIL Induction in ChemosensitizationCancer Research, 2008
- From the bench to the bedside: emerging new treatments in multiple myelomaBest Practice & Research Clinical Haematology, 2007
- Global chromatin compaction limits the strength of the DNA damage responseThe Journal of cell biology, 2007
- Chromatin Modifications and Their FunctionCell, 2007
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancerNature Reviews Cancer, 2006
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003